𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The UMD TP53 database and website: update and revisions

✍ Scribed by Dalil Hamroun; Shunsuke Kato; Chikashi Ishioka; Mireille Claustres; Christophe Béroud; Thierry Soussi


Book ID
102259244
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
346 KB
Volume
27
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Mutation of the p53 gene is the most frequent genetic alteration found in human cancer, but it is also the most frequently reported with more than 22,000 mutations published in 2,000 papers. In 1991, we developed a database and software to handle and analyze all this information. The database has been widely used for clinical analysis and molecular epidemiology. We have expanded the scope of the database by integrating structural, phylogenetic and biological information on wild-type (wt) and mutant TP53. Integration of the TP53 mutant activity database provides unique information that will be useful to both clinicians and scientists. All of this information is available from a new website (www.umd.be:2072/) that will generate a detailed informative page for every TP53 mutant in the database. New tools to check TP53 mutations and minimize errors found in the literature are also available.


📜 SIMILAR VOLUMES


UMD (Universal Mutation Database): 2005
✍ Christophe Béroud; Dalil Hamroun; Gwenaëlle Collod-Béroud; Catherine Boileau; Th 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

With the completion of the Human Genome Project, our vision of human genetic diseases has changed. The cloning of new disease-causing genes can now be performed in silico, and thousands of mutations are being identified in diagnostic and research laboratories yearly. Knowledge about these mutations

The UMD-p53 database: New mutations and
✍ Christophe Béroud; Thierry Soussi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The tumor suppressor gene TP53 (p53) is the most extensively studied gene involved in human cancers. More than 1,400 publications have reported mutations of this gene in 150 cancer types for a total of 14,971 mutations. To exploit this huge bulk of data, specific analytic tools were highly warranted

Update of the UMD-FBN1 mutation database
✍ Gwenaëlle Collod-Béroud; Saga Le Bourdelles; Lesley Ades; Leena Ala-Kokko; Patri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Communicated by Mark H. Paalman Fibrillin is the major component of extracellular microfibrils. Mutations in the fibrillin gene on chromosome 15 (FBN1) were first described in the heritable connective disorder, Marfan syndrome (MFS). FBN1 has also been shown to harbor mutations related to a spe

The IARC TP53 database: New online mutat
✍ Magali Olivier; Ros Eeles; Monica Hollstein; Mohammed A. Khan; Curtis C. Harris; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Communicated by Richard G.H. Cotton Mutations in the tumor suppressor gene TP53 are frequent in most human cancers. Comparison of the mutation patterns in different cancers may reveal clues on the natural history of the disease. Over the past 10 years, several databases of TP53 mutations have been d

Impact of mutant p53 functional properti
✍ Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V. Tavtigian; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

The tumor suppressor gene TP53 is frequently mutated in human cancers. More than 75% of all mutations are missense substitutions that have been extensively analyzed in various yeast and human cell assays. The International Agency for Research on Cancer (IARC) TP53 database (www-p53.iarc.fr) compiles

The UMD-LDLR database: additions to the
✍ Ludovic Villéger; Marianne Abifadel; Delphine Allard; Jean-Pierre Rabès; Rochell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Mutations in the LDL receptor gene (LDLR) cause familial hypercholesterolemia (FH), one of the most frequent hereditary dominant disorders. The protein defect was identified in 1973, the gene was localized by in situ hybridization in 1985, and since, a growing number of mutations have been reported.